AtriCure (ATRC) Short-term Investments (2010 - 2024)

AtriCure (ATRC) has 15 years of Short-term Investments data on file, last reported at $8.0 million in Q2 2024.

• On a quarterly basis, Short-term Investments fell 86.64% year-over-year to $8.0 million in Q2 2024; TTM through Jun 2024 was $8.0 million, a 86.64% decrease from a year earlier, with the FY2023 full-year figure at $53.0 million, down 15.93% from the prior year.
• Short-term Investments for Q2 2024 stood at $8.0 million, down from $41.0 million in the prior quarter.
• Over the last five years, Short-term Investments for ATRC reached as high as $202.3 million in Q4 2020 and fell as low as $8.0 million in Q2 2024.
• Historically, Short-term Investments has averaged $85.5 million across 5 years, with a median of $68.9 million in 2022.
• Across the five-year window, Short-term Investments jumped 328.91% in 2020 and tumbled 86.64% in 2024, its largest moves.
• Year by year, Short-term Investments stood at $202.3 million in 2020, then sank by 62.71% to $75.4 million in 2021, then slipped by 16.47% to $63.0 million in 2022, then retreated by 15.93% to $53.0 million in 2023, then slumped by 84.93% to $8.0 million in 2024.
• Per Business Quant data, the three most recent Short-term Investments figures were $8.0 million in Q2 2024, $41.0 million in Q1 2024, and $53.0 million in Q4 2023.